Javad Mahmoudi

Javad Mahmoudi

Auto-generated profile, based on publicly available information

Javad Mahmoudi

Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2014 in Medical Principles and Practice
Verified
Journal Article
Open access
PDF file
SSSaeed Sadigh-Eteghad
Saeed Sadigh-Eteghad
BSBabak Sabermarouf
Babak Sabermarouf
AMAlireza Majdi
Alireza Majdi
MTMahnaz Talebi
Mahnaz Talebi
MFMehdi Farhoudi
Mehdi Farhoudi
JMJavad Mahmoudi
Javad Mahmoudi
Alzheimer's disease (AD) is the most prevalent form of dementia which affects people older than 60 years of age. In AD, the dysregulation of the amyloid-beta (Aβ) level leads to the appearance of senile plaques which contain Aβ depositions. Aβ is a complex biological molecule which interacts with many types of receptors and/or forms insoluble assemblies and, eventually, its nonphysiological depositions alternate with the normal neuronal conditions. In this situation, AD signs appear and the patients experience marked cognitional disabilities. In general, intellect, social skills, personality, and memory are influenced by this disease and, in the long run, it leads to a reduction in quality of life and life expectancy. Due to the pivotal role of Aβ in the pathobiology of AD, a great deal of effort has been made to reveal its exact role in neuronal dysfunctions and to finding efficacious therapeutic strategies against its adverse neuronal outcomes. Hence, the determination of its different molecular assemblies and the mechanisms underlying its pathological effects are of interest. In the present paper, some of the well-established structural forms of Aβ, its interactions with various receptors and possible molecular and cellular mechanisms underlying its neurotoxicity are discussed. In addition, several Aβ-based rodent models of AD are reviewed.

23 October 2019 in Photobiomodulation, Photomedicine, and Laser Surgery
Verified
Journal Article
Closed access
FSFarzad Salehpour
Farzad Salehpour
PCPaolo Cassano
Paolo Cassano
NRNaser Rouhi
Naser Rouhi
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
LTLuis De Taboada
Luis De Taboada
JMJavad Mahmoudi
Javad Mahmoudi
Background and objective: Photobiomodulation (PBM) therapy is a promising and noninvasive approach to stimulate neuronal function and improve brain repair. The optimization of PBM parameters is important to maximize effectiveness and tolerability. Several studies have reported on the penetration of visible-to-near-infrared (NIR) light through various animal and human tissues. Scientific findings on the penetration of PBM light vary, likely due to use of different irradiation parameters and to different characteristics of the subject such as species, age, and gender. Materials and methods: In this article, we review published data on PBM penetration through the tissues of the head in both animal and human species. The patterns of visible-to-NIR light penetration are summarized based on the following study specifications: wavelength, coherence, operation mode, beam type and size, irradiation site, species, age, and gender. Results: The average penetration of transcranial red/NIR (630–810 nm) light ranged 60–70% in C57BL/6 mouse (skull), 1–10% in BALB/c mouse (skull), 10–40% in Sprague–Dawley rats (scalp plus skull), 20% in Oryctolagus cuniculus rabbit (skull), 0.11% in pig (scalp plus skull), and 0.2–10% in humans (scalp plus skull). The observed variation in the reported values is due to the difference in factors (e.g., wavelengths, light coherence, tissue thickness, and anatomic irradiation site) used by researchers. It seems that these data challenge the applicability of the animal model data on transcranial PBM to humans. Nevertheless, two animal models seem particularly promising, as they approximate penetration in humans: (I) Penetration of 808 nm laser through the scalp plus skull was 0.11% in the pig head; (II) Penetration of 810 nm laser through intact skull was 1.75% in BALB/c mouse. Conclusions: In conclusion, it is worthwhile mentioning that since the effectiveness of brain PBM is closely dependent on the amount of light energy reaching the target neurons, further quantitative estimation of light penetration depth should be performed to validate the current findings.

1 January 2019 in Brain Research Bulletin
Verified
Journal Article
Closed access
FSFarzad Salehpour
Farzad Salehpour
FFFereshteh Farajdokht
Fereshteh Farajdokht
PCPaolo Cassano
Paolo Cassano
SSSaeed Sadigh-Eteghad
Saeed Sadigh-Eteghad
MEMarjan Erfani
Marjan Erfani
JMJavad Mahmoudi
Javad Mahmoudi

30 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSaeed Sadigh-Eteghad
Saeed Sadigh-Eteghad
AMAlireza Majdi
Alireza Majdi
SMSarah K McCann
Sarah K McCann
JMJavad Mahmoudi
Javad Mahmoudi
MVManouchehr S Vafaee
Manouchehr S Vafaee
MMMalcolm R Macleod
Malcolm R Macleod
Animal models are commonly used in brain ageing research. Amongst these, models where rodents are exposed to d-galactose are held to recapitulate a number of features of ageing including neurobehavioral and neurochemical changes. However, results from animal studies are often inconsistent. To better understand the characteristics of the model and effects of d-galactose on neurobehavioral and neurochemical outcomes in rodents we performed a systematic review and meta-analysis. We applied random-effects meta-analysis to evaluate the effect of study features. Our results give an overview of the characteristics of the d-galactose rodent ageing model, including neurobehavioral and neurochemical outcomes. We found that few studies took measures to reduce risks of bias, and substantial heterogeneity in the reported effects of d-galactose in included studies. This highlights the need for improvements in the use of the d-galactose rodent ageing model if it is to provide useful in the development of drugs to treat human ageing.

31 January 2020 in Reviews in the Neurosciences
Verified
Journal Article
Closed access
PDF file
AMAlireza Majdi
Alireza Majdi
SSSaeed Sadigh-Eteghad
Saeed Sadigh-Eteghad
SASepideh Rahigh Aghsan
Sepideh Rahigh Aghsan
FFFereshteh Farajdokht
Fereshteh Farajdokht
SVSeyed Mehdi Vatandoust
Seyed Mehdi Vatandoust
JMJavad Mahmoudi
Javad Mahmoudi
The link between histopathological hallmarks of Alzheimer’s disease (AD), i.e. amyloid plaques, and neurofibrillary tangles, and AD-associated cognitive impairment, has long been established. However, the introduction of interactions between amyloid-beta (Aβ) as well as hyperphosphorylated tau, and the cholinergic system to the territory of descriptive neuropathology has drastically changed this field by adding the theory of synaptic neurotransmission to the toxic pas de deux in AD. Accumulating data show that a multitarget approach involving all amyloid, tau, and cholinergic hypotheses could better explain the evolution of events happening in AD. Various species of both Aβ and tau could be traced in cholinergic neurons of the basal forebrain system early in the course of the disease. These molecules induce degeneration in the neurons of this system. Reciprocally, aberrant cholinergic system modulation promotes changes in amyloid precursor protein (APP) metabolism and tau phosphorylation, resulting in neurotoxicity, neuroinflammation, and neuronal death. Altogether, these changes may better correlate with the clinical findings and cognitive impairment detected in AD patients. Failure of several of Aβ- and tau-related therapies further highlights the need for special attention to molecules that target all of these mentioned pathologic changes. Another noteworthy fact here is that none of the popular hypotheses of AD such as amyloidopathy or tauopathy seem to be responsible for the changes observed in AD alone. Thus, the main culprit should be sought higher in the stream somewhere in APP metabolism or Wnt signaling in the cholinergic system of the basal forebrain. Future studies should target these pathological events.

1 March 2018 in Brain Research
Verified
Journal Article
Closed access
FSFarzad Salehpour
Farzad Salehpour
FFFereshteh Farajdokht
Fereshteh Farajdokht
MEMarjan Erfani
Marjan Erfani
SSSaeed Sadigh-Eteghad
Saeed Sadigh-Eteghad
SSSiamak Sandoghchian Shotorbani
Siamak Sandoghchian Shotorbani
JMJavad Mahmoudi
Javad Mahmoudi